Description of the torcetrapib series of cholesteryl ester transfer protein inhibitors, including mechanism of action
Open Access
- 1 March 2006
- journal article
- Published by Elsevier in Journal of Lipid Research
- Vol. 47 (3) , 537-552
- https://doi.org/10.1194/jlr.m500349-jlr200
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Effects of Cholesteryl Ester Transfer Protein Inhibition on High-Density Lipoprotein Subspecies, Apolipoprotein A-I Metabolism, and Fecal Sterol ExcretionArteriosclerosis, Thrombosis, and Vascular Biology, 2005
- Cholesteryl Ester Transfer ProteinArteriosclerosis, Thrombosis, and Vascular Biology, 2003
- Inactivation of Cholesteryl Ester Transfer Protein by Cysteine ModificationBiochemical and Biophysical Research Communications, 1996
- Kinetics and Inhibition of Lipid Exchange Catalyzed by Plasma Cholesteryl Ester Transfer Protein (Lipid transfer protein)Biochemistry, 1995
- Increased catabolic rate of low density lipoproteins in humans with cholesteryl ester transfer protein deficiency.Journal of Clinical Investigation, 1995
- Molecular Determinants of Plasma Cholesteryl Ester Transfer Protein Binding to High Density LipoproteinsJournal of Biological Chemistry, 1995
- Delayed catabolism of high density lipoprotein apolipoproteins A-I and A-II in human cholesteryl ester transfer protein deficiency.Journal of Clinical Investigation, 1993
- Different locations of cholesteryl ester transfer protein and phospholipid transfer protein activities in plasmaAtherosclerosis, 1991
- Distribution and concentration of cholesteryl ester transfer protein in plasma of normolipemic subjects.Journal of Clinical Investigation, 1990
- Cholesteryl ester transfer activityAtherosclerosis, 1984